The cluster effect of Shaanxi planting industry is prominent, and Xi'an derived organisms use the "the Belt and Road" to open up the Central Asian market
2025-03-25
In 2025, Shaanxi Province's plant extract industry will continue to lead the country, relying on abundant medicinal plant resources (such as astragalus, licorice, etc.) and mature industrial clusters. The province has formed a full industry chain layout covering planting, research and development, production, and export. According to data from the China Chamber of Commerce for Import and Export of Medicines and Health Products, the export value of plant extracts in China will reach 23.88 billion yuan in 2023, with Shaanxi contributing over 30%. Among them, Xi'an derived biology, with EU certified products such as Chinese herbal antioxidants, saw a year-on-year increase of 45% in export value.
With the deepening of the "the Belt and Road" strategy, the company has successfully entered Kazakhstan, Uzbekistan and other Central Asian markets by optimizing international logistics (such as the cold chain transportation of China Europe trains) to reduce the transportation cost to US $0.5/kg. In addition, the national policy of "health food filing system" has released a market dividend of over 600 billion yuan. The company has accelerated its layout in the field of functional food raw materials and launched a new product of mulberry leaf polysaccharide extract for metabolic syndrome. It is expected to increase production capacity by 20% within the year.
keywords： astragalus,licorice
Related News
Quick Links
+86(029)89297929
B-1806, ZhongGang International, Fengcheng 12th Road Xian Shaanxi 710018 China